Immediate Implant Using Socket Shield Technique With Xenogenic Bone Graft
Launched by ALEXANDRIA UNIVERSITY · Jul 25, 2020
Trial Information
Current as of May 20, 2025
Unknown status
Keywords
ClinConnect Summary
16 patients who are admitted to the outpatient clinic of Oral and Maxillofacial Surgery Department, are divided into two study groups. Control group will receive an immediate implant with modified socket shield technique. Test group will receive immediate implant with modified socket shield and deproteinized bovine bone mineral (DBBM) put in the buccal gap. Outcome measurement is primary and secondary implant stability measurement and CBCT evaluation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age more than 18 years old irrespective of the gender
- • One or more of non-restorable (fractured or decayed) tooth/teeth in the upper aesthetic regions (incisors, premolars).
- • Free from periodontal diseases.
- • Sufficient bone volume to allow placement of an implant.
- • Ability to read and sign an informed consent form
- • Adequate buccolingual width to allow for a buccal gap presence.
- Exclusion Criteria:
- • A medical history that contraindicates oral surgical treatment (uncontrolled/untreated diabetes mellitus, immuno-compromised status, radio/chemotherapy of the oral and maxillofacial region, treatment with oral and/or intravenous amino-bisphosphonates).
- • Untreated periodontal disease.
- • Vertical root fractures on the buccal aspect.
- • Tooth /teeth with horizontal fractures below bone level.
- • Tooth /teeth with external or internal resorptions.
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials